The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review
- PMID: 32336282
- PMCID: PMC7183616
- DOI: 10.1186/s12964-020-00569-y
The role of Neurotensin and its receptors in non-gastrointestinal cancers: a review
Abstract
Background: Neurotensin, originally isolated in 1973 has both endocrine and neuromodulator activity and acts through its three main receptors. Their role in promoting tumour cell proliferation, migration, DNA synthesis has been studied in a wide range of cancers. Expression of Neurotensin and its receptors has also been correlated to prognosis and prediction to treatment.
Main body: The effects of NT are mediated through mitogen-activated protein kinases, epidermal growth factor receptors and phosphatidylinositol-3 kinases amongst others. This review is a comprehensive summary of the molecular pathways by which Neurotensin and its receptors act in cancer cells.
Conclusion: Identifying the role of Neurotensin in the underlying molecular mechanisms in various cancers can give way to developing new agnostic drugs and personalizing treatment according to the genomic structure of various cancers. Video abstract.
Keywords: Cancer; Neurotensin; Neurotensin receptors.
Conflict of interest statement
The authors declare they have no conflict of interest.
Figures








Similar articles
-
Oncogenic role of neurotensin and neurotensin receptors in various cancers.Clin Exp Pharmacol Physiol. 2017 Aug;44(8):841-846. doi: 10.1111/1440-1681.12787. Clin Exp Pharmacol Physiol. 2017. PMID: 28556374 Review.
-
The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.Biochimie. 2011 Sep;93(9):1369-78. doi: 10.1016/j.biochi.2011.04.024. Epub 2011 May 17. Biochimie. 2011. PMID: 21605619 Review.
-
Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line.Gastroenterology. 2002 Oct;123(4):1135-43. doi: 10.1053/gast.2002.36000. Gastroenterology. 2002. PMID: 12360476
-
Neurotensin receptors: binding properties, transduction pathways, and structure.Cell Mol Neurobiol. 1995 Oct;15(5):501-12. doi: 10.1007/BF02071313. Cell Mol Neurobiol. 1995. PMID: 8719037 Free PMC article. Review.
-
Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review.Eur J Pharmacol. 2013 Sep 15;716(1-3):54-60. doi: 10.1016/j.ejphar.2013.03.004. Epub 2013 Mar 14. Eur J Pharmacol. 2013. PMID: 23500196 Review.
Cited by
-
Nano-Radiopharmaceuticals in Colon Cancer: Current Applications, Challenges, and Future Directions.Pharmaceuticals (Basel). 2025 Feb 14;18(2):257. doi: 10.3390/ph18020257. Pharmaceuticals (Basel). 2025. PMID: 40006069 Free PMC article. Review.
-
New Insights in the Control of Fat Homeostasis: The Role of Neurotensin.Int J Mol Sci. 2022 Feb 17;23(4):2209. doi: 10.3390/ijms23042209. Int J Mol Sci. 2022. PMID: 35216326 Free PMC article. Review.
-
Diagnosis of Prostate Cancer with a Neurotensin-Bombesin Radioligand Combination-First Preclinical Results.Pharmaceutics. 2024 Sep 19;16(9):1223. doi: 10.3390/pharmaceutics16091223. Pharmaceutics. 2024. PMID: 39339259 Free PMC article.
-
68Ga-DOTA-NT-20.3 Neurotensin Receptor 1 PET Imaging as a Surrogate for Neuroendocrine Differentiation of Prostate Cancer.J Nucl Med. 2022 Sep;63(9):1394-1400. doi: 10.2967/jnumed.121.263132. Epub 2022 Feb 17. J Nucl Med. 2022. PMID: 35177423 Free PMC article.
-
Optimizing the Profile of [99mTc]Tc-NT(7-13) Tracers in Pancreatic Cancer Models by Means of Protease Inhibitors.Int J Mol Sci. 2020 Oct 26;21(21):7926. doi: 10.3390/ijms21217926. Int J Mol Sci. 2020. PMID: 33114537 Free PMC article.
References
-
- Kitabgi P. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Curr Opin Drug Discov Devel. 2002;5(5):764–776. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials